Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Jun;16(6):1002-4.
doi: 10.1038/mt.2008.89.

SERCA2a gene therapy for heart failure: ready for primetime?

Muthu Periasamy  1 , Anuradha Kalyanasundaram
Affiliations
Comment

SERCA2a gene therapy for heart failure: ready for primetime?

Muthu Periasamy et al. Mol Ther. 2008 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Altered Ca2+ transport in heart failure and targets for gene therapy
NCX, sodium-calcium exchanger; PLB, phospholamban; RyR2, ryanodine receptor; SR, sarcoplasmic reticulum.
See this image and copyright information in PMC

Comment on

References

    1. Cohn JN. Overview of the treatment of heart failure. Am J Cardiol. 1997;80:2L–6L. - PubMed
    1. Ly H, Kawase Y, Yoneyama R, Hajjar RJ. Gene therapy in the treatment of heart failure. Physiology (Bethesda) 2007;22:81–96. - PubMed
    1. del Monte F, Hajjar RJ, Harding SE. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res. 2001;88:E66–E67. - PubMed
    1. Lebeche D, Kaprelian R, del Monte F, Tomaselli G, Gwathmey JK, Schwartz A, et al. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation. 2004;110:3435–3443. - PubMed
    1. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA. 1998;95:5251–5256. - PMC - PubMed

Publication types

Substances